Cart
sales@molnova.com
Suberosin
CAS No. 581-31-7
Suberosin ( —— )
Catalog No. M20470 CAS No. 581-31-7
Suberosin exhibits anti-inflammatory and anticoagulant activities it also shows biting deterrent activity against Aedes aegypti it may be useful for use as mosquito larvicidal agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSuberosin
-
NoteResearch use only not for human use.
-
Brief DescriptionSuberosin exhibits anti-inflammatory and anticoagulant activities it also shows biting deterrent activity against Aedes aegypti it may be useful for use as mosquito larvicidal agent.
-
DescriptionSuberosin exhibits anti-inflammatory and anticoagulant activities it also shows biting deterrent activity against Aedes aegypti it may be useful for use as mosquito larvicidal agent.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number581-31-7
-
Formula Weight244.28
-
Molecular FormulaC15H16O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc2oc(=O)ccc2cc1C\C=C(\C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chen Y C Tsai W J Wu M H et al. Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF-AT and NF-B?[J]. British Journal of Pharmacology 2007 150(3):298-312.
molnova catalog
related products
-
SGC-CBP30
SGC-CBP30 is an effective CREBBP/EP300 inhibitor (IC50: 21/38 nM).
-
(S,R,S)-AHPC TFA
(S,R,S)-AHPC TFA (VH032-NH2 TFA) is the VH032-based VHL ligand used in the recruitment of the von Hippel-Lindau (VHL) protein.
-
A 1120
A 1120 is a nonretinoid retinol-binding protein 4 (RBP4) antagonist (Ki: 8.3 nM), which disrupts the interaction between RBP4 and its binding partner transthyretin.
